[PDF][PDF] Inflammation, apoptosis and autophagy as critical players in vascular dementia.
XX Wang, B Zhang, R Xia, QY Jia - European Review for …, 2020 - europeanreview.org
Vascular dementia is the second-most cause of dementia, characterized by cerebral infarcts,
white matter lesions, myelin loss and often amyloid angiopathy. Hence, vascular damage is …
white matter lesions, myelin loss and often amyloid angiopathy. Hence, vascular damage is …
Neuroprotective factors of the retina and their role in promoting survival of retinal ganglion cells: a review
E Fudalej, M Justyniarska, K Kasarełło… - Ophthalmic …, 2021 - karger.com
Retinal ganglion cells (RGCs) play a crucial role in the visual pathway. As their axons form
the optic nerve, apoptosis of these cells causes neurodegenerative vision loss. RGC death …
the optic nerve, apoptosis of these cells causes neurodegenerative vision loss. RGC death …
Protein misfolding, aggregation and mechanism of amyloid cytotoxicity: An overview and therapeutic strategies to inhibit aggregation
Protein and peptides are converted from their soluble forms into highly ordered fibrillar
aggregates under various conditions inside the cell. Such transitions confer diverse …
aggregates under various conditions inside the cell. Such transitions confer diverse …
ATP-mediated signalling in the central synapses
U Lalo, Y Pankratov - Neuropharmacology, 2023 - Elsevier
ATP released from the synaptic terminals and astrocytes can activate neuronal P2 receptors
at a variety of locations across the CNS. Although the postsynaptic ATP-mediated signalling …
at a variety of locations across the CNS. Although the postsynaptic ATP-mediated signalling …
Memantine derivatives as multitarget agents in Alzheimer's disease
G Marotta, F Basagni, M Rosini, A Minarini - Molecules, 2020 - mdpi.com
Memantine (3, 5-dimethyladamantan-1-amine) is an orally active, noncompetitive N-methyl-
D-aspartate receptor (NMDAR) antagonist approved for treatment of moderate-to-severe …
D-aspartate receptor (NMDAR) antagonist approved for treatment of moderate-to-severe …
Purinergic receptors of the central nervous system: biology, PET ligands, and their applications
H Zarrinmayeh, PR Territo - Molecular Imaging, 2020 - journals.sagepub.com
Purinergic receptors play important roles in central nervous system (CNS). These receptors
are involved in cellular neuroinflammatory responses that regulate functions of neurons …
are involved in cellular neuroinflammatory responses that regulate functions of neurons …
Blocking P2RX7 attenuates ferroptosis in endothelium and reduces HG-induced hemorrhagic transformation after MCAO by inhibiting ERK1/2 and P53 signaling …
Hyperglycemia is a risk factor for poor prognosis after acute ischemic stroke and promote the
occurrence of hemorrhagic transformation (HT). The activation of P2RX7 play an important …
occurrence of hemorrhagic transformation (HT). The activation of P2RX7 play an important …
CircRNA-ceRNA network revealing the potential regulatory roles of CircRNA in Alzheimer's disease involved the cGMP-PKG signal pathway
Y Zhang, L Qian, Y Liu, Y Liu, W Yu… - Frontiers in Molecular …, 2021 - frontiersin.org
Background: Alzheimer's disease (AD) is a chronic progressive neurodegenerative disease.
The characteristic pathologies include extracellular senile plaques formed by β-amyloid …
The characteristic pathologies include extracellular senile plaques formed by β-amyloid …
A role of low-density lipoprotein receptor-related protein 4 (LRP4) in astrocytic Aβ clearance
Amyloid-β (Aβ) deposition occurs years before cognitive symptoms appear and is
considered a cause of Alzheimer9s disease (AD). The imbalance of Aβ production and …
considered a cause of Alzheimer9s disease (AD). The imbalance of Aβ production and …
Potential of caffeine in Alzheimer's disease—a review of experimental studies
P Londzin, M Zamora, B Kąkol, A Taborek… - Nutrients, 2021 - mdpi.com
Alzheimer's disease (AD) is the most common type of dementia leading to progressive
memory loss and cognitive impairment. Considering that pharmacological treatment options …
memory loss and cognitive impairment. Considering that pharmacological treatment options …